Storage and handling
Other Information Do not store above 30 o C or 86 o F.
Botanics Complexion Refining Day Moisture Lotion Sunscreen SPF 12
- Manufacturer
- Boots Retail USA Inc | The Boots Company PLC | BCM Ltd
- Effective date
- 2010-01-27
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-05-31 22:23:26
Label at a glance#
ProductBotanics Complexion Refining Day Moisture Lotion Sunscreen SPF 12
Active ingredientOctinoxate, Avobenzone
Label structure20 sections
Contacts and useful links#
Websitewww.boots.com
www.boots.com
www.boots.comLabel contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
Active Ingredients Purpose
Avobenzone 3% Sunscreens
Octinoxate 5%
OTC - PURPOSE SECTION
Uses
- Provides moderate protection against the adverse effects of the sun
- Higher SPF gives more protection
WARNINGS AND PRECAUTIONS SECTION
Warnings
For external use only
When using this product keep out of eyes. If contact occurs rinse thoroughly with cold water. Avoid direct contact with fabric.
HOW SUPPLIED SECTION
Colour may vary due to natural extracts
OTC - ASK DOCTOR SECTION
Stop use and ask a doctor if rash or irritation develops and lasts.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children. If swallowed, get medical help.
INDICATIONS & USAGE SECTION
Directions
- Massage onto face and neck with gentle upward strokes.
- Apply evenly at least 15 minutes before sun exposure.
- Reapply as required.
- Not intended for children under the age of 12.
- Not intended for protection while sunbathing.
STORAGE AND HANDLING SECTION
Other Information
Do not store above 30oC or 86oF.
INACTIVE INGREDIENT SECTION
Inactive ingredients
Aqua (Water), C12-15 alkyl benzoate, Butylene glycol, Dimethicone, Glycerin, Sorbitan stearate, Cetyl alcohol, C18-36 acid glycol ester, Kaolin, Rosmarinus officinalis (Rosemary) leaf extract, Phenoxyethanol, Butyrospermum parkii (Shea butter), Lauryl methacrylate/glycol dimethacrylate cross polymer, Methylparaben, Carbomer, Propylparaben, Sucrose cocoate, Xanthan gum, Limonene, Parfum (Fragrance), Potassium hydroxide, Butylparaben, Ethylparaben, Linalool, Tetrasodium EDTA, Isobutylparaben, Dipropylene glycol, Citronellol, Zinc chloride, BHT, Tetrasodium pyrophosphate, Cinnamyl alcohol, Citral
OTC - QUESTIONS SECTION
USA: Questions? 1-866-75-BOOTS
DESCRIPTION SECTION
ACTIVE PLANT EXTRACTS
Plant extracts at levels that really work, combined and formulated for outstanding product performance.
Naturally.
Ideal for Blemish Prone Skin
Skin needs moisture, but too much oil can clog pores and lead to blemishes. This light lotion hydrates and helps to soothe the skin while oil absorbing powders help to reduce shine.
Oil Free. Non-pore blocking.
Dermatologically tested.
INFORMATION FOR PATIENTS SECTION
Mfd in the U.K. for BBI NG2 3AA. UK.
Dist in the USA by Boots Retail USA Inc. Stamford CT 06901
DESCRIPTION SECTION
Tube label
ACTIVE PLANT EXTRACTS
Plant extract at levels that really work, combined and formulated for outstanding product performance. Naturally.
This light lotion hydrates and soothes the skin while oil absorbing powders help to reduce shine.
Oil free. Non-pore blocking. SPF 12.
Dermatologically tested.
EXTRAITS ACTIFS DE PLANTES
Des extraits de plantes à des degrés efficaces, agencés et formulés pour un produit d'une performance exceptionnelle. Tout naturellement.
Cette lotion légère hydrate et aide à adoucir la peau pendant que les poudres absorbantes contribuent à réduire le lustre.
Sans huile. N'obstrue pas les pores. FPS 12.
Dermo-testé
INDICATIONS & USAGE SECTION
DIRECTIONS: Massage onto face and neck using gentle upward strokes.
MODE D'EMPLOI: Massez sur le visage et le cou en suivant des mouvements ascendants.
OTC - ACTIVE INGREDIENT SECTION
Active ingredients: Avobenzone 3.0%, Octinoxate 5.0%
WARNINGS AND PRECAUTIONS SECTION
WARNINGS: Avoid getting directly in eyes. If contact occurs rinse thoroughly with cold water. Avoid direct contact with fabric.
MISE EN GARDE: Éviter tout contact avec les yeux. En cas de projection, rincer immédiatement à l'eau froide. Éviter tout contact direct avec du tissu.
HOW SUPPLIED SECTION
Colour may vary due to natural extracts.
La couleur peut varier en raison des extraits naturels.INFORMATION FOR PATIENTS SECTION
EXTRACTS AUTHENTICATED BY ROYAL BOTANIC GARDENS KEW
EXTRAITS APPROUVES PAR LES JARDINS BOTANIQUES ROYAUX DE KEW
Mfd in the U.K. for/Fabriqué au R.-U. pour BBI NG2 3AA. UK.
Dist in the USA by/aux É.-U. par Boots Retail USA Inc. Stamford CT 06901
USA/Canada: Questions? 1-866-75-BOOTS
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
Carton label
COMPLEXION REFINING
Day Moisture Lotion Sunscreen SPF 12
Rosemary protects and clarifies
AFFINAGE DU TEINT
Lotion Hydratante Jour FPS12
Le Romarin protège et éclaircit
BOOTS
The Power of Plants
BOTANICS
75ml e 2.5 US Fl. Oz
CR Day Moisture Lotion carton.jpg
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
Day Moisture Lotion Sunscreen SPF 12
Rosemary protects and clarifies
Lotion Hydratante Jouse FPS12
Le Romarin protège et éclaircit
Boots
The Power of Plants
BOTANICS
75ml e 2.5 US Fl. Oz
CR Day Moisture Lotion label.jpg
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 030ce964-9b2d-45aa-b5d3-f78ce03ef61c | Product name | 2 | 20250515 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 68472-028-01 | 2019-10-21 | C162847 | 48780-1 | 956f9ecf-dcad-621f-e053-dbdaa90a74ad | Carton and tube labelling |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68472-028-01 | Botanics Complexion Refining Day Moisture Lotion Sunscreen SPF 12 | 75 mL in 1 TUBE | LOTION | 75 | 1 | |
| 68472-028-01 | Botanics Complexion Refining Day Moisture Lotion Sunscreen SPF 12 | 1 in 1 CARTON | LOTION | 1 | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Avobenzone | ACTIVE INGREDIENT | G63QQF2NOX | 1 | |
| Octinoxate | ACTIVE INGREDIENT | 4Y5P7MUD51 | 1 | |
| Avobenzone | ACTIVE MOIETY | G63QQF2NOX | 1 | |
| Octinoxate | ACTIVE MOIETY | 4Y5P7MUD51 | 1 | |
| Butylated Hydroxytoluene | INACTIVE INGREDIENT | 1P9D0Z171K | 1 | |
| Butylene Glycol | INACTIVE INGREDIENT | 3XUS85K0RA | 1 | |
| Butylparaben | INACTIVE INGREDIENT | 3QPI1U3FV8 | 1 | |
| Carbomer Homopolymer Type C | INACTIVE INGREDIENT | 4Q93RCW27E | 1 | |
| Cetyl Alcohol | INACTIVE INGREDIENT | 936JST6JCN | 1 | |
| Dimethicone | INACTIVE INGREDIENT | 92RU3N3Y1O | 1 | |
| Ethylparaben | INACTIVE INGREDIENT | 14255EXE39 | 1 | |
| Glycerin | INACTIVE INGREDIENT | PDC6A3C0OX | 1 | |
| Isobutylparaben | INACTIVE INGREDIENT | 0QQJ25X58G | 1 | |
| Kaolin | INACTIVE INGREDIENT | 24H4NWX5CO | 1 | |
| Methylparaben | INACTIVE INGREDIENT | A2I8C7HI9T | 1 | |
| Phenoxyethanol | INACTIVE INGREDIENT | HIE492ZZ3T | 1 | |
| Potassium Hydroxide | INACTIVE INGREDIENT | WZH3C48M4T | 1 | |
| Propylparaben | INACTIVE INGREDIENT | Z8IX2SC1OH | 1 | |
| Rosemary | INACTIVE INGREDIENT | IJ67X351P9 | 1 | |
| Shea Butter | INACTIVE INGREDIENT | K49155WL9Y | 1 | |
| Sodium Pyrophosphate | INACTIVE INGREDIENT | O352864B8Z | 1 | |
| Sorbitan Monostearate | INACTIVE INGREDIENT | NVZ4I0H58X | 1 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | 1 | |
| Xanthan Gum | INACTIVE INGREDIENT | TTV12P4NEE | 1 | |
| Zinc Chloride | INACTIVE INGREDIENT | 86Q357L16B | 1 |
Products#
Every source-derived product name is available through these pages.
- Botanics Complexion Refining Day Moisture Lotion Sunscreen SPF 12
- Octinoxate and Avobenzone
- Octinoxate
- Avobenzone
- Water
- Butylene Glycol
- Dimethicone
- Glycerin
- Sorbitan Monostearate
- Cetyl Alcohol
- Kaolin
- Rosemary
- Phenoxyethanol
- Shea Butter
- Methylparaben
- Carbomer Homopolymer Type C
- Propylparaben
- Xanthan Gum
- Potassium Hydroxide
- Butylparaben
- Ethylparaben
- Isobutylparaben
- Zinc Chloride
- Butylated Hydroxytoluene
- Sodium Pyrophosphate
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 68472-028 | 68472-028-01 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Glycerin | GLYCERIN | PDC6A3C0OX | DOUCHE / VAGINAL | 1 %w/w | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SYSTEM / IONTOPHORESIS | 168.1 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | TABLET, EXTENDED RELEASE / ORAL | 7 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | INJECTION / INTRADERMAL | 1.6 %w/v | ||
| Propylparaben | PROPYLPARABEN | Z8IX2SC1OH | INJECTION / PARENTERAL | 2 mg | ||
| Ethylparaben | ETHYLPARABEN | 14255EXE39 | SOLUTION / ORAL | 14 mg | ||
| Butylated Hydroxytoluene | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | TABLET / ORAL | 3 mg | ||
| Sodium Pyrophosphate | SODIUM PYROPHOSPHATE | O352864B8Z | INJECTION / INTRAVENOUS | 12 mg | ||
| Propylparaben | PROPYLPARABEN | Z8IX2SC1OH | GEL / VAGINAL | 2 mg | ||
| Sorbitan Monostearate | SORBITAN MONOSTEARATE | NVZ4I0H58X | OINTMENT / TOPICAL | NA | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | ELIXIR / ORAL | 800 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | FILM, EXTENDED RELEASE / BUCCAL | 34 mg | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | INJECTION, SOLUTION / INTRAVENOUS | 45 mg | ||
| Propylparaben | PROPYLPARABEN | Z8IX2SC1OH | TABLET, EXTENDED RELEASE / ORAL | 0.12 mg | ||
| Xanthan Gum | XANTHAN GUM | TTV12P4NEE | SUSPENSION / TOPICAL | 0.11 %w/v | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SUPPOSITORY / VAGINAL | 227.9 mg | ||
| Butylated Hydroxytoluene | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | CREAM, AUGMENTED / TOPICAL | 0.2 %w/w | ||
| Propylparaben | PROPYLPARABEN | Z8IX2SC1OH | CONCENTRATE / ORAL | 2.5 mg/5ml | ||
| Xanthan Gum | XANTHAN GUM | TTV12P4NEE | AEROSOL, FOAM / TOPICAL | 0.27 %w/w | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | ENEMA / RECTAL | 0.18 %w/v | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SUSPENSION, EXTENDED RELEASE / ORAL | 2000 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION / RESPIRATORY (INHALATION) | 5 %w/w | ||
| Butylated Hydroxytoluene | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | SUPPOSITORY / VAGINAL | NA | ||
| Butylated Hydroxytoluene | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | SUPPOSITORY / RECTAL | 1 mg | ||
| Butylparaben | BUTYLPARABEN | 3QPI1U3FV8 | SOLUTION / RECTAL | 0.01 %w/v | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | SOLUTION / IONTOPHORESIS | 0.1 %w/v | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | AEROSOL, FOAM / VAGINAL | 0.1 %w/w | ||
| Potassium Hydroxide | POTASSIUM HYDROXIDE | WZH3C48M4T | GEL / TOPICAL | 3 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | CREAM / VAGINAL | 60 mg | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | INJECTION, SUSPENSION / INTRAMUSCULAR | 1 mg | ||
| Butylated Hydroxytoluene | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | SOAP / TOPICAL | 0.02 %w/w | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION / TOPICAL | 1971 mg | ||
| Butylparaben | BUTYLPARABEN | 3QPI1U3FV8 | CAPSULE / ORAL | NA | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | INJECTION / PERINEURAL | 80 mg | ||
| Propylparaben | PROPYLPARABEN | Z8IX2SC1OH | SUSPENSION / ORAL | 64 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | INJECTION / INTRAVENOUS | 33750 mg | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | LOTION / TOPICAL | 351 mg | ||
| Xanthan Gum | XANTHAN GUM | TTV12P4NEE | PASTE / ORAL | 1050 mg | ||
| Cetyl Alcohol | CETYL ALCOHOL | 936JST6JCN | SUSPENSION / TOPICAL | 2.01 %w/w | ||
| Phenoxyethanol | PHENOXYETHANOL | HIE492ZZ3T | AEROSOL / TOPICAL | 1.05 %w/w | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | DROPS / ORAL | 300 mg/1ml | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | TABLET, COATED / ORAL | 0.8 mg | ||
| Carbomer Homopolymer Type C | CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED) | 4Q93RCW27E | OINTMENT, AUGMENTED / TOPICAL | 23 mg | ||
| Xanthan Gum | XANTHAN GUM | TTV12P4NEE | ENEMA / RECTAL | 150 mg | ||
| Phenoxyethanol | PHENOXYETHANOL | HIE492ZZ3T | CREAM / TOPICAL | 57 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | GEL / TRANSDERMAL | 500 mg | ||
| Cetyl Alcohol | CETYL ALCOHOL | 936JST6JCN | CREAM / VAGINAL | 200 mg | ||
| Kaolin | KAOLIN | 24H4NWX5CO | TABLET, COATED / ORAL | 52.44 mg | ||
| Cetyl Alcohol | CETYL ALCOHOL | 936JST6JCN | SOLUTION / TOPICAL | NA | ||
| Butylated Hydroxytoluene | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | CREAM / TOPICAL | 6 mg | ||
| Cetyl Alcohol | CETYL ALCOHOL | 936JST6JCN | CREAM / TOPICAL | 1280 mg | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | SOLUTION / IRRIGATION | 2 %w/v | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | EMULSION / OPHTHALMIC | 3 mg | ||
| Potassium Hydroxide | POTASSIUM HYDROXIDE | WZH3C48M4T | PASTILLE / ORAL | ADJ PH | ||
| Xanthan Gum | XANTHAN GUM | TTV12P4NEE | GRANULE, FOR SUSPENSION, EXTENDED RELEASE / ORAL | 2350 mg | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | LIQUID / ORAL | 162 mg | ||
| Carbomer Homopolymer Type C | CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED) | 4Q93RCW27E | GEL / OPHTHALMIC | 4 %w/w | ||
| Butylparaben | BUTYLPARABEN | 3QPI1U3FV8 | LIQUID / TOPICAL | 0.02 %w/w | ||
| Kaolin | KAOLIN | 24H4NWX5CO | POWDER / TOPICAL | 10056 mg | ||
| Butylated Hydroxytoluene | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | AEROSOL, FOAM / TOPICAL | 4 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| b84ce3ef-a468-413c-ad33-3a4e67ad5c09 | f6c7afd7-0bca-49bc-8e8b-aa84522acfc9 | 2010-01-27 | Warnings | b84ce3ef-a468-413c-ad33-3a4e67ad5c09 f6c7afd7-0bca-49bc-8e8b-aa84522acfc9 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.